154 related articles for article (PubMed ID: 9142728)
1. Indium-111 labelled lymphocytes: isotope distribution and cell division.
Kuyama J; McCormack A; George AJ; Heelan BT; Osman S; Batchelor JR; Peters AM
Eur J Nucl Med; 1997 May; 24(5):488-96. PubMed ID: 9142728
[TBL] [Abstract][Full Text] [Related]
2. Comparison of three different methods for radiolabelling human activated T lymphocytes.
Botti C; Negri DR; Seregni E; Ramakrishna V; Arienti F; Maffioli L; Lombardo C; Bogni A; Pascali C; Crippa F; Massaron S; Remonti F; Nerini-Molteni S; Canevari S; Bombardieri E
Eur J Nucl Med; 1997 May; 24(5):497-504. PubMed ID: 9142729
[TBL] [Abstract][Full Text] [Related]
3. Measurement of lymphocyte traffic with indium-111.
Issekutz T; Chin W; Hay JB
Clin Exp Immunol; 1980 Jan; 39(1):215-21. PubMed ID: 7389193
[TBL] [Abstract][Full Text] [Related]
4. Active and passive mechanisms of [fluorine-18] fluorodeoxyglucose uptake by proliferating and prenecrotic cancer cells in vivo: a microautoradiographic study.
Kubota R; Kubota K; Yamada S; Tada M; Ido T; Tamahashi N
J Nucl Med; 1994 Jun; 35(6):1067-75. PubMed ID: 8195872
[TBL] [Abstract][Full Text] [Related]
5. In vivo imaging of rat lymphocytes with an indium 111-labelled anti-T cell monoclonal antibody: a comparison with indium 111-labelled lymphocytes.
Loutfi I; Chisholm PM; Bevan D; Lavender JP
Eur J Nucl Med; 1990; 16(2):69-76. PubMed ID: 2311621
[TBL] [Abstract][Full Text] [Related]
6. Factors influencing the fate of 111indium-labelled lymphocytes after transfer to syngeneic rats.
Sparshott SM; Sharma H; Kelly JD; Ford WL
J Immunol Methods; 1981; 41(3):303-20. PubMed ID: 6785358
[TBL] [Abstract][Full Text] [Related]
7. Quantification of the chromosomal radiation damage induced by labelling of leukocytes with [18F]FDG.
Miñana E; Roldán M; Chivato T; Martínez T; Fuente T
Nucl Med Biol; 2015 Sep; 42(9):720-3. PubMed ID: 26025178
[TBL] [Abstract][Full Text] [Related]
8. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
9. [Initial 111In-platelet kinetics: indicator of platelet sequestration/destruction site or quality control of platelet labelling?].
Todorović-Tirnanić M; Obradović V; Rolović Z; Suvajdzić N; Elezović I; Colović M; Pavlović S; Starcević V; Bosnjaković V
Glas Srp Akad Nauka Med; 2005; (48):101-18. PubMed ID: 16405234
[TBL] [Abstract][Full Text] [Related]
10. Organ and tumor distribution of (18F)-2-fluoro-2-deoxy-D-glucose in fasting and non-fasting rats.
Paul R; Kiuru A; Söderström KO; Tuominen J; Johansson R; Haaparanta M; Roeda D; Solin O
Life Sci; 1987 Apr; 40(16):1609-16. PubMed ID: 3031405
[TBL] [Abstract][Full Text] [Related]
11. Targeting of lymphocytes with 111In-labelled monoclonal antibodies.
Loutfi I; Batchelor JR; Chisholm PM; Epenetos AA; Lavender JP
Nucl Med Commun; 1988 Oct; 9(10):787-96. PubMed ID: 3211438
[TBL] [Abstract][Full Text] [Related]
12. Preparation of a viable population of indium-111-labelled human blood platelets.
Heyns AD; Badenhorst PN; Pieters H; Lötter MG; Minnaar PC; Duyvené de Wit LJ; Van Reenen OR; Retief FP
Thromb Haemost; 1980 Feb; 42(5):1473-82. PubMed ID: 6768151
[TBL] [Abstract][Full Text] [Related]
13. Requirements for the induction of allospecific CD8+ suppressor T cells in the rat primary mixed lymphocyte response. CD4+, CD45R+ T cells, or supernatant factor.
Frankel AH; Sayegh MH; Rothstein DM; Milford EL; Carpenter CB
Transplantation; 1989 Oct; 48(4):639-46. PubMed ID: 2572083
[TBL] [Abstract][Full Text] [Related]
14. Cell labelling and cell damage with indium-111 acetylacetone-an alternative to indium 111 oxine.
Danpure HJ; Osman S
Br J Radiol; 1981 Jul; 54(643):597-601. PubMed ID: 6789920
[TBL] [Abstract][Full Text] [Related]
15.
Faivre L; Chaussard M; Vercellino L; Vanneaux V; Hosten B; Teixera K; Parietti V; Merlet P; Sarda-Mantel L; Rizzo-Padoin N; Larghero J
Curr Res Transl Med; 2016; 64(3):141-148. PubMed ID: 27765274
[TBL] [Abstract][Full Text] [Related]
16. A method for labeling cells for positron emission tomography (PET) studies.
Melder RJ; Elmaleh D; Brownell AL; Brownell GL; Jain RK
J Immunol Methods; 1994 Sep; 175(1):79-87. PubMed ID: 7930641
[TBL] [Abstract][Full Text] [Related]
17. A method for following human lymphocyte traffic using indium-111 oxine labelling.
Wagstaff J; Gibson C; Thatcher N; Ford WL; Sharma H; Benson W; Crowther D
Clin Exp Immunol; 1981 Mar; 43(3):435-42. PubMed ID: 7285387
[TBL] [Abstract][Full Text] [Related]
18. Indium-III: a new radionuclide label for studying human platelet kinetics.
Heaton WA; Davis HH; Welch MJ; Mathias CJ; Joist JH; Sherman LA; Siegel BA
Br J Haematol; 1979 Aug; 42(4):613-22. PubMed ID: 476012
[TBL] [Abstract][Full Text] [Related]
19. Pre-clinical comparison of [DTPA0] octreotide, [DTPA0,Tyr3] octreotide and [DOTA0,Tyr3] octreotide as carriers for somatostatin receptor-targeted scintigraphy and radionuclide therapy.
De Jong M; Bakker WH; Breeman WA; Bernard BF; Hofland LJ; Visser TJ; Srinivasan A; Schmidt M; Béhé M; Mäcke HR; Krenning EP
Int J Cancer; 1998 Jan; 75(3):406-11. PubMed ID: 9455802
[TBL] [Abstract][Full Text] [Related]
20. In vivo evaluation of 111In-labeled T-lymphocyte homing in experimental colitis.
van Montfrans C; Bennink RJ; de Bruin K; de Jonge W; Verberne HJ; Ten Kate FJ; van Deventer SJ; Te Velde AA
J Nucl Med; 2004 Oct; 45(10):1759-65. PubMed ID: 15471846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]